基于免疫调节探讨茶多酚及表没食子儿茶素没食子酸酯的抗肿瘤机制

李光达; 王婧; 许晶; 谢美雯; 周义斌; 侯丽

doi:10.6039/j.issn.1001-0408.2022.24.25

您当前的位置：

首页 >

文章列表页 >

基于免疫调节探讨茶多酚及表没食子儿茶素没食子酸酯的抗肿瘤机制

综述 | 更新时间：2023-02-22

- 基于免疫调节探讨茶多酚及表没食子儿茶素没食子酸酯的抗肿瘤机制
- Investigation on anti-tumor mechanism of tea polyphenol and epigallocatechin gallate based on immunity regulation
- 中国药房 2022年33卷第24期页码：3067-3072
- 作者机构：
  
  北京中医药大学东直门医院血液肿瘤科，北京　100700
- 作者简介：
  
  博士研究生。研究方向：中西医结合防治恶性肿瘤。E-mail：liguangdachn@163.com
  主任医师，教授，博士生导师。研究方向：中西医结合防治恶性肿瘤与血液病。E-mail：houli1203@126.com
- 基金信息：
  
  基金项目国家自然科学基金资助项目(No.82172760);首都卫生发展科研专项项目(No.首发2020-2-4193)
- DOI：10.6039/j.issn.1001-0408.2022.24.25
  中图分类号： R96
- 纸质出版日期：2022-12-30，
  
  收稿日期：2022-07-18，
  
  修回日期：2022-11-24，
扫描看全文
李光达,王婧,许晶等.基于免疫调节探讨茶多酚及表没食子儿茶素没食子酸酯的抗肿瘤机制^Δ[J].中国药房,2022,33(24):3067-3072.

LI Guangda,WANG Jing,XU Jing,et al.Investigation on anti-tumor mechanism of tea polyphenol and epigallocatechin gallate based on immunity regulation[J].ZHONGGUO YAOFANG,2022,33(24):3067-3072.
李光达,王婧,许晶等.基于免疫调节探讨茶多酚及表没食子儿茶素没食子酸酯的抗肿瘤机制^Δ[J].中国药房,2022,33(24):3067-3072. DOI： 10.6039/j.issn.1001-0408.2022.24.25.

LI Guangda,WANG Jing,XU Jing,et al.Investigation on anti-tumor mechanism of tea polyphenol and epigallocatechin gallate based on immunity regulation[J].ZHONGGUO YAOFANG,2022,33(24):3067-3072. DOI： 10.6039/j.issn.1001-0408.2022.24.25.

摘要

茶多酚是茶叶的主要活性物质之一，表没食子儿茶素没食子酸酯（EGCG）则是茶多酚发挥生物作用的主要活性成分。二者作为免疫调节剂可用于肿瘤的治疗。本文从提高免疫效应、改善免疫逃逸两个方面综述茶多酚及EGCG的抗肿瘤作用机制。结果发现，茶多酚及EGCG不仅可以通过活化免疫细胞与促进细胞因子分泌来提高抗肿瘤免疫效应，还可通过调节免疫抑制细胞、调控免疫检查点、调节细胞因子、抑制免疫调节酶与Janus激酶/信号转导和转录激活子（JAK/STAT）通路来改善肿瘤免疫逃逸，在肿瘤免疫治疗方面具有较大潜力。

Abstract

Tea polyphenol （TP） is the main active constituent in tea， and epigallocatechin gallate （EGCG） is the main active constituent of TP that plays a biological role. Both of them can be used as immunomodulators in the treatment of tumor. In this paper， the anti-tumor mechanism of TP and EGCG was summarized from two aspects： enhancing immune effect and improving immune escape. The results showed that TP and EGCG could not only enhance the anti-tumor immune effect by promoting the activity of immune cells and the secretion of cytokines， but also improve tumor immune escape by regulating immunosuppressive cells， immune checkpoints， cytokines， immunomodulatory enzymes and JAK/STAT pathway， which has great potential in tumor immunotherapy.

关键词

茶多酚表没食子儿茶素没食子酸酯免疫调节免疫效应免疫逃逸抗肿瘤机制

Keywords

epigallocatechin gallateimmunoregulationimmune effectimmune escapeantitumormechanism

references

XING L，ZHANG H，QI R，et al. Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols[J]. J Agric Food Chem，2019，67（4）：1029-1043.

葛华，丛聪，詹皓. 茶多酚抑制肿瘤作用研究进展[J]. 人民军医，2020，63（1）：92-95.

THAKUR V S，GUPTA K，GUPTA S. The chemopreventive and chemotherapeutic potentials of tea polyphenols[J]. Curr Pharm Biotechnol，2012，13（1）：191-199.

SHIRAKAMI Y，SHIMIZU M，MORIWAKI H. Cancer chemoprevention with green tea catechins：from bench to bed[J]. Curr Drug Targets，2012，13（14）：1842-1857.

MOODY R，WILSON K，JAWOROWSKI A，et al. Na-tural compounds with potential to modulate cancer therapies and self-reactive immune cells[J]. Cancers（Basel），2020，12（3）：E673.

向莉，王爱荣，江高峰. 肿瘤免疫循环调节研究进展[J]. 肿瘤药学，2021，11（4）：420-425.

HUANG A C，CHENG H Y，LIN T S，et al. Epigalloca-techin gallate（EGCG），influences a murine WEHI-3 leukemia model in vivo through enhancing phagocytosis of macrophages and populations of T- and B-cells[J]. In Vivo，2013，27（5）：627-634.

HSIEH D S. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles[J]. Biomaterials，2011，32（30）：7633-7640.

陈清勇，方睿，杨凌，等. 化疗对肺癌患者外周血Th1/Th2的影响及茶多酚的调控研究[J]. 临床内科杂志，2007（5）：307-309.

陆鸿飞. 绿茶茶多酚胶囊联合化疗抑制晚期非小细胞肺癌新生血管生成的临床研究[D]. 北京：北京中医药大学，2013.

JANG J Y，LEE J K，JEON Y K，et al. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization[J]. BMC Cancer，2013，13：421.

RAWANGKAN A，WONGSIRISIN P，NAMIKI K，et al. Green tea catechin is an alternative immune checkpoint inhibitor that inhibits PD-L1 expression and lung tumor growth[J]. Molecules，2018，23（8）：E2071.

KATIYAR S，ELMETS C A，KATIYAR S K，et al. Green tea and skin cancer：photoimmunology，angiogenesis and DNA repair[J]. J Nutr Biochem，2007，18（5）：287-296.

KATIYAR S K. Green tea prevents non-melanoma skin cancer by enhancing DNA repair[J]. Arch Biochem Biophys，2011，508（2）：152-158.

SANTILLI G，PIOTROWSKA I，CANTILENA S，et al. Polyphenon E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells[J]. Clin Cancer Res，2013，19（5）：1116-1125.

徐平. EGCG通过调控MDSCs介导免疫抑制阻滞肿瘤免疫逃逸研究[D]. 杭州：浙江大学，2016.

XU P，YAN F，ZHAO Y，et al. Green tea polyphenol EGCG attenuates MDSCs-mediated immunosuppression through canonical and non-canonical pathways in a 4T1 murine breast cancer model[J]. Nutrients，2020，12（4）：E1042.

D’ARENA G，SIMEON V，DE MARTINO L，et al. Regulatory T-cell modulation by green tea in chronic lymphocytic leukemia[J]. Int J Immunopathol Pharmacol，2013，26（1）：117-125.

CALGAROTTO A K，LONGHINI A L，PERICOLE DE SOUZA F V，et al. Immunomodulatory effect of green tea treatment in combination with low-dose chemotherapy in elderly acute myeloid leukemia patients with myelodysplasia-related changes[J]. Integr Cancer Ther，2021，20：15347354211002647.

WANG J Z，MAN G，CHAN T H，et al. A prodrug of green tea polyphenol（-）-epigallocatechin-3-gallate（Pro-EGCG）serves as a novel angiogenesis inhibitor in endometrial cancer[J]. Cancer Lett，2018，412：10-20.

MUKHERJEE S，BAIDOO J N E，SAMPAT S，et al. Liposomal TriCurin，a synergistic combination of curcumin，epicatechin gallate and resveratrol，repolarizes tumor-associated microglia/macrophages，and eliminates glioblastoma（GBM）and GBM stem cells[J]. Molecules，2018，23（1）：E201.

RAVINDRAN MENON D，LI Y，YAMAUCHI T，et al. EGCG inhibits tumor growth in melanoma by targeting JAK-STAT signaling and its downstream PD-L1/PD-L2-PD1 axis in tumors and enhancing cytotoxic T-cell responses[J]. Pharmaceuticals（Basel），2021，14（11）：1081.

MUKHERJEE S，SIDDIQUI M A，DAYAL S，et al. Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells[J]. J Inflamm Res，2014，7：89-101.

朱宝和，何裕隆，詹文华，等. EGCG抑制IL-6诱导肿瘤血管生成的作用及机制[J]. 中国普通外科杂志，2011，20（7）：725-730.

SALEH F，RAGHUPATHY R，ASFAR S，et al. Analysis of the effect of the active compound of green tea（EGCG）on the proliferation of peripheral blood mononuclear cells[J]. BMC Complement Altern Med，2014，14：322.

OGAWA K，HARA T，SHIMIZU M，et al. Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan，an inhibitor of indoleamine 2，3-dioxygenase[J]. Cancer Sci，2012，103（5）：951-958.

OGAWA K，HARA T，SHIMIZU M，et al.（-）-Epigalloca-techin gallate inhibits the expression of indoleamine 2，3-dioxygenase in human colorectal cancer cells[J]. Oncol Lett，2012，4（3）：546-550.

CHENG C W，SHIEH P C，LIN Y C，et al. Indoleamine 2，3-dioxygenase，an immunomodulatory protein，is suppressed by（-）-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signa-ling in human oral cancer cells[J]. J Agric Food Chem，2010，58（2）：887-894.

TANG S N，FU J，SHANKAR S，et al. EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer[J]. PLoS One，2012，7（2）：e31067.

LIN H Y，HOU S C，CHEN S C，et al.（-）-Epigalloca-techin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells[J]. J Agric Food Chem，2012，60（10）：2480-2489.

GONZALEZ SUAREZ N，RODRIGUEZ TORRES S，OUANOUKI A，et al. EGCG inhibits adipose-derived mesenchymal stem cells differentiation into adipocytes and prevents a STAT3-mediated paracrine oncogenic control of triple-negative breast cancer cell invasive phenotype[J]. Molecules，2021，26（6）：1506.

WANG S，LI Z，MA Y，et al. Immunomodulatory effects of green tea polyphenols[J]. Molecules，2021，26（12）：3755.

PALUCKA A K，et al. The basis of oncoimmunology[J]. Cell，2016，164（6）：1233-1247.

梁春艳，邢海洲，姜中兴. 髓源性抑制细胞在肿瘤免疫中的作用[J]. 河南医学研究，2021，30（28）：5374-5378.

HATZIOANNOU A，BOUMPAS A，PAPADOPOULOU M，et al. Regulatory T cells in autoimmunity and cancer：a duplicitous lifestyle[J]. Front Immunol，2021，12：731947.

李赟. MDSCs、Tregs、PD-L1与晚期胃癌化疗疗效及预后关系[D]. 石河子：石河子大学，2020.

周姚邑，赵新新，陈沅沅，等. 肿瘤免疫检查点抑制剂及其联合疗法的研究进展[J]. 中国药房，2020，31（7）：890-896.

LI B，CHAN H L，CHEN P. Immune checkpoint inhibitors：basics and challenges[J]. Curr Med Chem，2019，26（17）：3009-3025.

GUO Y，LIANG J，LIU B，et al. Molecular mechanism of food-derived polyphenols on PD-L1 dimerization：a molecular dynamics simulation study[J]. Int J Mol Sci，2021，22（20）：10924.

WU P，ZHANG H，YIN Y，et al. Engineered EGCG-containing biomimetic nanoassemblies as effective delivery platform for enhanced cancer therapy[J]. Adv Sci（Weinh），2022，9（15）：e2105894.

张永珍. 血清中细胞因子TNF-α、IL-10、TGF-β1的水平在肝癌患者中的表达意义[J]. 罕少疾病杂志，2022，29（8）：53-54.

CASEY S C，AMEDEI A，AQUILANO K，et al. Cancer prevention and therapy through the modulation of the tumor microenvironment[J]. Semin Cancer Biol，2015，35：S199-S223.

GUO Y X，LIU Y，WU W，et al. Indoleamine 2，3-dioxygenase（Ido）inhibitors and their nanomedicines for cancer immunotherapy[J]. Biomaterials，2021，276：121018.

张康平，张琪，于恺英，等. 吲哚胺2，3-双加氧酶抑制剂临床研究现状[J]. 中国医学前沿杂志（电子版），2020，12（1）：20-26.

SALMINEN A，KAUPPINEN A，KAARNIRANTA K. AMPK activation inhibits the functions of myeloid-derived suppressor cells（MDSC）：impact on cancer and aging[J]. J Mol Med（Berl），2019，97（8）：1049-1064.

ZERDES I，MATIKAS A，BERGH J，et al. Genetic，transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer：biology and clinical correlations[J]. Oncogene，2018，37（34）：4639-4661.

HUANG S C，KAO Y H，SHIH S F，et al. Epigalloca-techin-3-gallate exhibits immunomodulatory effects in human primary T cells[J]. Biochem Biophys Res Commun，2021，550：70-76.

AZAMBUJA J H，MANCUSO R I，VIA F，et al. Protective effect of green tea and epigallocatechin-3-gallate in a LPS-induced systemic inflammation model[J]. J Nutr Biochem，2022，101：108920.

SHIRAKAMI Y，SHIMIZU M，TSURUMI H，et al. EGCG and polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS[J]. Mol Med Rep，2008，1（3）：355-361.

KANG T H，LEE J H，SONG C K，et al. Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination[J]. Cancer Res，2007，67（2）：802-811.

FILIPPINI T，MALAVOLTI M，BORRELLI F，et al. Green tea（Camellia sinensis）for the prevention of cancer[J]. Cochrane Database Syst Rev，2020，3：CD005004.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

清热活血汤改善大鼠心肌缺血再灌注损伤的药效成分及作用机制研究

藤黄健骨胶囊质控成分定量分析方法建立及潜在作用机制预测

固本安神方对绝经综合征模型大鼠的改善作用机制研究 ^Δ

槟榔的细胞毒理研究进展

药物创新审评机制的分析与改进建议